Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
3.920
+0.030 (0.77%)
Sep 9, 2025, 12:35 PM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2020
Period Ending
Dec '24 Dec '20
Genetic Therapies
2.98M
Log In
Genetic Therapies Growth
-42.74%
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2020
Period Ending
Dec '24 Dec '20
United States
2.98M
Log In
United States Growth
-42.74%
Log In